MedX Health Corp (CVE:MDX – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as C$0.10 and last traded at C$0.09, with a volume of 826190 shares traded. The stock had previously closed at C$0.10.
MedX Health Trading Down 10.5%
The firm has a market capitalization of C$22.96 million, a P/E ratio of -4.25 and a beta of 1.26. The stock’s 50-day simple moving average is C$0.07 and its 200-day simple moving average is C$0.07.
MedX Health Company Profile
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market.
See Also
- Five stocks we like better than MedX Health
- 3 Small Caps With Big Return Potential
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- How to Profit From Value Investing
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Palantir Defies Bears, Leads S&P 500 in 2025
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
